All Stories

  1. Ocular COVID-19: Eyes as a reservoir to conceal and spread SARS-CoV-2

    Article • Infectious Disorders - Drug Targets, July 2020, Bentham Science Publishers

    Abdul Mannan Baig, Saara Ahmad

  2. Future Oncotargets: Targeting Overexpressed Conserved Protein Targets in Androgen Independent Prostate Cancer Cell Lines

    Article • Anti-Cancer Agents in Medicinal Chemistry, July 2020, Bentham Science Publishers

    Abdul Mannan Baig, Areeba Khaleeq

  3. “Proposals for Amendments in the Diagnosis and Treatment of Encephalitis caused by Free-living Amoebae”

    Article • Infectious Disorders - Drug Targets, May 2020, Bentham Science Publishers

    Abdul Mannan Baig

  4. Global Warming Favors Pathogenicity of the Brain-Eating Amoebae

    Article • Anti-Infective Agents, December 2018, Bentham Science Publishers

    Abdul Mannan Baig

  5. Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae

    Article • Current Drug Targets, November 2018, Bentham Science Publishers

    Abdul Mannan Baig

  6. Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer’s Disease

    Article • ACS Chemical Neuroscience, August 2018, American Chemical Society (ACS)

    Abdul Mannan Baig

  7. Evolution of pH buffers and water homeostasis in eukaryotes: homology between humans and Acanthamoeba proteins

    Article • Future Microbiology, January 2018, Future Medicine

    Abdul Mannan Baig

  8. Drug Target Discovery Methods In Targeting Neurotropic Parasitic Amoebae

    Article • ACS Chemical Neuroscience, December 2017, American Chemical Society (ACS)

    Abdul Mannan Baig

  9. Building Bridges through Science

    Article • Neuron, November 2017, Elsevier

    Abdul Mannan Baig

  10. Traced on the Timeline: Discovery of Acetylcholine and the Components of the Human Cholinergic System in a Primitive Unicellular Eukaryote Acanthamoeba spp.

    Article • ACS Chemical Neuroscience, October 2017, American Chemical Society (ACS)

    Abdul Mannan Baig

  11. Is There a Cholinergic Survival Incentive for Neurotropic Parasites in the Brain?

    Article • ACS Chemical Neuroscience, October 2017, American Chemical Society (ACS)

    Abdul Mannan Baig

  12. Antibiotic Effects of Loperamide: Homology of Human Targets of Loperamide with Targets in Acanthamoeba spp.

    Article • Recent Patents on Anti-Infective Drug Discovery, October 2017, Bentham Science Publishers

    Abdul Mannan Baig

  13. Bioinformatic Insights on Target Receptors of Amiodarone in Human and Acanthamoeba castellanii

    Article • Infectious Disorders - Drug Targets, September 2017, Bentham Science Publishers

    Abdul Mannan Baig

  14. Emerging Insights for Better Delivery of Chemicals and Stem Cells to the Brain

    Article • ACS Chemical Neuroscience, April 2017, American Chemical Society (ACS)

    Abdul Mannan Baig

  15. Differential receptor dependencies

    Article • Anti-Cancer Drugs, January 2017, Wolters Kluwer Health

    Abdul Mannan Baig

  16. Evidence of a M1-muscarinic GPCR homolog in unicellular eukaryotes: featuring Acanthamoeba spp bioinformatics 3D-modelling and experimentations

    Article • Journal of Receptors and Signal Transduction, September 2016, Taylor & Francis

    Abdul Mannan Baig

  17. Primary Amoebic Meningoencephalitis: Neurochemotaxis and Neurotropic Preferences ofNaegleria fowleri

    Article • ACS Chemical Neuroscience, August 2016, American Chemical Society (ACS)

    Abdul Mannan Baig

  18. Primary Amoebic Meningoencephalitis Preventive Nose Plugs: Prophylaxis AgainstNaegleria fowleri

    Article • Journal of Medical Devices, January 2016, ASME International

    Abdul Mannan Baig

  19. A proposed cascade of vascular events leading to granulomatous amoebic encephalitis

    Article • Microbial Pathogenesis, November 2015, Elsevier

    Abdul Mannan Baig

  20. Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an ‘inside job’ done by the host immune response?

    Article • Acta Tropica, August 2015, Elsevier

    Abdul Mannan Baig

  21. Tackling infection owing to brain-eating amoeba

    Article • Acta Tropica, February 2015, Elsevier

    Abdul Mannan Baig

  22. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris

    Article • Experimental Parasitology, November 2014, Elsevier

    Abdul Mannan Baig

  23. Designer’s microglia with novel delivery system in neurodegenerative diseases

    Article • Medical Hypotheses, October 2014, Elsevier

    Abdul Mannan Baig

  24. Anesthesia With Antiamoebic Effects

    Article • Journal of Neurosurgical Anesthesiology, October 2014, Wolters Kluwer Health

    Abdul Mannan Baig

  25. Granulomatous amoebic encephalitis: ghost response of an immunocompromised host?

    Article • Journal of Medical Microbiology, September 2014, Society for General Microbiology

    Abdul Mannan Baig

  26. Laboratory testing of clinically approved drugs against Balamuthia mandrillaris

    Article • World Journal of Microbiology and Biotechnology, May 2014, Springer Science + Business Media

    Abdul Mannan Baig

  27. Primary amoebic meningoencephalitis: amoebicidal effects of clinically approved drugs against Naegleria fowleri

    Article • Journal of Medical Microbiology, February 2014, Society for General Microbiology

    Abdul Mannan Baig

  28. Novel Chemotherapeutic Strategies in the Management of Primary Amoebic Meningoencephalitis Due toNaegleria fowleri

    Article • CNS Neuroscience & Therapeutics, January 2014, Wiley

    Abdul Mannan Baig

  29. Cloned Microglias with Novel Delivery System in Multiple Sclerosis

    Article • Journal of Stem Cell Research & Therapy, January 2014, OMICS Publishing Group

    Abdul Mannan Baig

  30. In VitroEfficacies of Clinically Available Drugs against Growth and Viability of an Acanthamoeba castellanii Keratitis Isolate Belonging to the T4 Genotype

    Article • Antimicrobial Agents and Chemotherapy, May 2013, ASM Journals

    Abdul Mannan Baig